141 related articles for article (PubMed ID: 8887473)
21. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.
Reimann KA; Watson A; Dailey PJ; Lin W; Lord CI; Steenbeke TD; Parker RA; Axthelm MK; Karlsson GB
Virology; 1999 Mar; 256(1):15-21. PubMed ID: 10087222
[TBL] [Abstract][Full Text] [Related]
22. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses.
Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K
J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943
[TBL] [Abstract][Full Text] [Related]
23. A molecular clone of simian-human immunodeficiency virus (DeltavpuSHIV(KU-1bMC33)) with a truncated, non-membrane-bound vpu results in rapid CD4(+) T cell loss and neuro-AIDS in pig-tailed macaques.
McCormick-Davis C; Dalton SB; Hout DR; Singh DK; Berman NE; Yong C; Pinson DM; Foresman L; Stephens EB
Virology; 2000 Jun; 272(1):112-26. PubMed ID: 10873754
[TBL] [Abstract][Full Text] [Related]
24. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus.
Nishino Y; Nakaya T; Fujinaga K; Kishi M; Azuma I; Ikuta K
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2241-51. PubMed ID: 7521392
[TBL] [Abstract][Full Text] [Related]
25. A simian human immunodeficiency virus with a nonfunctional Vpu (deltavpuSHIV(KU-1bMC33)) isolated from a macaque with neuroAIDS has selected for mutations in env and nef that contributed to its pathogenic phenotype.
Singh DK; McCormick C; Pacyniak E; Lawrence K; Dalton SB; Pinson DM; Sun F; Berman NE; Calvert M; Gunderson RS; Wong SW; Stephens EB
Virology; 2001 Mar; 282(1):123-40. PubMed ID: 11259196
[TBL] [Abstract][Full Text] [Related]
26. The construction and evaluation of SIV/HIV chimeras that express the envelope of European HIV type 1 isolates.
Ranjbar S; Jones S; Stott EJ; Almond N
AIDS Res Hum Retroviruses; 1997 Jun; 13(9):797-800. PubMed ID: 9171224
[TBL] [Abstract][Full Text] [Related]
27. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.
Korth MJ; Taylor MD; Katze MG
Virology; 1998 Aug; 247(2):265-73. PubMed ID: 9705919
[TBL] [Abstract][Full Text] [Related]
28. Functional analysis of vif genes derived from various primate immunodeficiency viruses.
Yamamoto Y; Saito Y; Iida S; Asano J; Sone S; Adachi A
Virus Genes; 1997; 14(3):195-200. PubMed ID: 9311564
[TBL] [Abstract][Full Text] [Related]
29. Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted.
Guan Y; Whitney JB; Detorio M; Wainberg MA
J Virol; 2001 May; 75(9):4056-67. PubMed ID: 11287555
[TBL] [Abstract][Full Text] [Related]
30. Infection of baboons with simian/human immunodeficiency viruses.
Allan JS; Ray P; Broussard S; Whitehead E; Hubbard G; Butler T; Brasky K; Luciw P; Cheng-Mayer C; Levy JA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):429-41. PubMed ID: 7627620
[TBL] [Abstract][Full Text] [Related]
31. Construction of gag-chimeric viruses between HIV-1 and SIVmac that are capable of productive multi-cycle infection.
Kamada K; Yoshida A; Khamsri B; Piroozmand A; Yamashita T; Uchiyama T; Fujita M; Adachi A
Microbes Infect; 2006 Apr; 8(4):1075-81. PubMed ID: 16520079
[TBL] [Abstract][Full Text] [Related]
32. Development of a novel rhesus macaque model with an infectious R5 simian-human immunodeficiency virus encoding HIV-1 CRF08_BC env.
Huang L; Kusagawa S; Zeng H; Yang G; Sun B; Miura T; Yang R
J Med Primatol; 2014 Feb; 43(1):11-21. PubMed ID: 24020838
[TBL] [Abstract][Full Text] [Related]
33. Scrambling of the amino acids within the transmembrane domain of Vpu results in a simian-human immunodeficiency virus (SHIVTM) that is less pathogenic for pig-tailed macaques.
Hout DR; Gomez ML; Pacyniak E; Gomez LM; Inbody SH; Mulcahy ER; Culley N; Pinson DM; Powers MF; Wong SW; Stephens EB
Virology; 2005 Aug; 339(1):56-69. PubMed ID: 15975620
[TBL] [Abstract][Full Text] [Related]
34. Modification of a loop sequence between alpha-helices 6 and 7 of virus capsid (CA) protein in a human immunodeficiency virus type 1 (HIV-1) derivative that has simian immunodeficiency virus (SIVmac239) vif and CA alpha-helices 4 and 5 loop improves replication in cynomolgus monkey cells.
Kuroishi A; Saito A; Shingai Y; Shioda T; Nomaguchi M; Adachi A; Akari H; Nakayama EE
Retrovirology; 2009 Aug; 6():70. PubMed ID: 19650891
[TBL] [Abstract][Full Text] [Related]
35. Properties of a chimeric simian-human immunodeficiency virus expressing an hybrid HIV-1 Nef/SIVmac Nef protein.
Bertsch C; Cluet D; Beyer C; Gloeckler L; Cecile A; Gut JP; Aubertin AM
Arch Virol; 2002 Oct; 147(10):1963-75. PubMed ID: 12376757
[TBL] [Abstract][Full Text] [Related]
36. Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells.
Kamada K; Igarashi T; Martin MA; Khamsri B; Hatcho K; Yamashita T; Fujita M; Uchiyama T; Adachi A
Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16959-64. PubMed ID: 17065315
[TBL] [Abstract][Full Text] [Related]
37. Genetic complementation between replication-defective mutants of HIV-1 and SIVagm.
Miura T; Shibata R; Adachi A; Kuwata T; Chen J; Jin M; Ido E; Hayami M
Arch Virol; 1996; 141(1):31-41. PubMed ID: 8629949
[TBL] [Abstract][Full Text] [Related]
38. SIV/HIV-1 chimeric viruses having HIV-1 env gene: a new animal model and a candidate for attenuated live vaccine.
Hayami M; Igarashi T
Leukemia; 1997 Apr; 11 Suppl 3():95-7. PubMed ID: 9209310
[TBL] [Abstract][Full Text] [Related]
39. The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses.
Bour S; Strebel K
J Virol; 1996 Dec; 70(12):8285-300. PubMed ID: 8970948
[TBL] [Abstract][Full Text] [Related]
40. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins.
Li J; Lord CI; Haseltine W; Letvin NL; Sodroski J
J Acquir Immune Defic Syndr (1988); 1992; 5(7):639-46. PubMed ID: 1613662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
